Novartis AG (NVSEF) Operating income 2016–2025
Novartis AG (NVSEF) annual operating income history from SEC filings — each fiscal year as reported.
$17.6BFY2025 · since FY2016: $8.3B → $17.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.6B | +21.3% |
| FY2024 | $14.5B | +48.9% |
| FY2023 | $9.8B | +22.9% |
| FY2022 | $7.9B | -21.0% |
| FY2021 | $10.1B | -0.9% |
| FY2020 | $10.2B | +11.7% |
| FY2019 | $9.1B | +8.1% |
| FY2018 | $8.4B | -3.4% |
| FY2017 | $8.7B | +5.2% |
| FY2016 | $8.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice